slotkoers
Korea S.E.
00:00:00 14-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
4.200
KRW
|
-4,55%
|
|
-5,51%
|
-4,55%
|
Fiscaal tijdperk: Giugno |
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
769.464
|
206.789
|
272.542
|
Bedrijfswaarde
1 |
810.801
|
310.025
|
387.122
|
K/w-verhouding
|
-18,4
x
|
-4,55
x
|
-6,63
x
|
Dividendrendement
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
238.457.616
x
|
13.284.923.921
x
|
156.110.072
x
|
Bedrijfswaarde/omzet
|
251.267.875
x
|
19.917.188.831
x
|
221.741.268
x
|
Bedrijfswaarde/EBITDA
|
-35,4
x
|
-10,8
x
|
-12,2
x
|
Bedrijfswaarde/FCF
|
-6,38
x
|
-3,16
x
|
-
|
FCF Yield
|
-15,7%
|
-31,7%
|
-
|
Price to Book
|
7,2
x
|
2,27
x
|
2,73
x
|
Aantal aandelen (in duizenden)
|
47.206
|
47.320
|
61.108
|
Referentieprijs
2 |
16.300
|
4.370
|
4.460
|
Datum van publicatie
|
01-03-22
|
01-03-23
|
29-08-23
|
Fiscaal tijdperk: Giugno |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
|
-
|
184,8
|
-
|
3.227
|
15,57
|
1.746
|
EBITDA
1 |
-2.769
|
-9.646
|
-19.499
|
-22.916
|
-28.693
|
-31.629
|
Bedrijfsresultaat (EBIT)
1 |
-3.112
|
-12.454
|
-22.601
|
-26.837
|
-36.631
|
-40.043
|
Operationele Marge
|
-
|
-6.740,96%
|
-
|
-831,68%
|
-235.333,31%
|
-2.293,61%
|
Resultaat voor belastingen (EBT)
1 |
10
|
-22.057
|
-31.033
|
-39.378
|
-49.718
|
-39.442
|
Nettowinst (verlies)
1 |
10
|
-22.057
|
-31.033
|
-39.378
|
-49.718
|
-39.442
|
Nettomarge
|
-
|
-11.938,78%
|
-
|
-1.220,33%
|
-319.407,01%
|
-2.259,19%
|
WPA
2 |
4,000
|
-694,0
|
-876,0
|
-886,0
|
-960,7
|
-672,4
|
Free Cash Flow
1 |
-24.758
|
-29.115
|
-4.038
|
-127.117
|
-98.250
|
-
|
FCF-marge
|
-
|
-15.758,82%
|
-
|
-3.939,36%
|
-631.195,54%
|
-
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
31-12-20
|
31-12-20
|
01-03-21
|
01-03-22
|
01-03-23
|
29-08-23
|
Fiscaal tijdperk: Juni |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
4.429
|
23.429
|
41.337
|
103.236
|
114.581
|
Nettokaspositie
1 |
1.249
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-0,4592
x
|
-1,202
x
|
-1,804
x
|
-3,598
x
|
-3,623
x
|
Free Cash Flow
1 |
-24.758
|
-29.115
|
-4.038
|
-127.117
|
-98.250
|
-
|
ROE (netto-inkomsten/eigen vermogen)
|
0,07%
|
-78%
|
-226%
|
-74,7%
|
-44,3%
|
-
|
ROA (netto-inkomsten/totale activa)
|
-3,48%
|
-9,87%
|
-23,1%
|
-13,1%
|
-9,85%
|
-
|
Totale activa
1 |
-287,4
|
223.508
|
134.382
|
301.680
|
504.735
|
-
|
Nettoactief per aandeel
2 |
13.872
|
815,0
|
-39,30
|
2.263
|
1.925
|
1.633
|
Cashflow per aandeel
2 |
9.199
|
327,0
|
119,0
|
779,0
|
252,0
|
744,0
|
Capex
1 |
23.554
|
8.380
|
2.969
|
97.392
|
84.642
|
35.435
|
Capex/omzet
|
-
|
4.535,62%
|
-
|
3.018,19%
|
543.775,64%
|
2.029,71%
|
Datum van publicatie
|
31-12-20
|
31-12-20
|
01-03-21
|
01-03-22
|
01-03-23
|
29-08-23
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -4,55% | 187 mln. | | +0,85% | 92,38 mld. | | -3,03% | 37,9 mld. | | -10,46% | 33,73 mld. | | +74,71% | 27,98 mld. | | -13,39% | 15,86 mld. | | -1,08% | 13,97 mld. | | -11,15% | 11,67 mld. | | +169,04% | 10,17 mld. | | -50,19% | 10,04 mld. |
Biofarmaceutica
|